JEFFREY C LAURENCE, MD
Osteopathic Medicine at 70 St, New York, NY

License number
New York 131121
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
520 E 70Th St #STARR-341, New York, NY 10021
Phone
(212) 746-2927
(212) 746-8869 (Fax)
(212) 746-0373
(212) 746-7481 (Fax)

Personal information

See more information about JEFFREY C LAURENCE at radaris.com
Name
Address
Phone
Jeffrey Laurence
525 68Th St, New York, NY 10021
(212) 746-3253

Professional information

See more information about JEFFREY C LAURENCE at trustoria.com
Jeffrey Conrad Laurence Photo 1
Jeffrey Conrad Laurence, New York NY

Jeffrey Conrad Laurence, New York NY

Specialties:
Internal Medicine, Hematology & Oncology, Hematology, Medical Oncology
Work:
NewYork-Presbyterian / Weill Cornell
525 E 68Th St, New York, NY 10065 Cornell Hematology/Oncology Faculty Practice Group
520 E 70Th St, New York, NY 10021
Education:
University of Chicago (1976)


Jeffrey C Laurence Photo 2
Jeffrey C Laurence, New York NY

Jeffrey C Laurence, New York NY

Specialties:
Internist
Address:
525 E 68Th St, New York, NY 10065
520 E 70Th St, New York, NY 10021
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Fellowship - Hematology
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine


Jeffrey Laurence Photo 3
Professor Of Medicine At Weill Cornell Medical College

Professor Of Medicine At Weill Cornell Medical College

Position:
Professor of Medicine at Weill Cornell Medical College
Location:
Greater New York City Area
Industry:
Research
Work:
Weill Cornell Medical College - Professor of Medicine


Jeffrey C Laurence Photo 4
Dr. Jeffrey C Laurence, New York NY - MD (Doctor of Medicine)

Dr. Jeffrey C Laurence, New York NY - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
NEW YORK HOSP CORNELL MED CTR
525 E 68Th St, New York 10065
(212) 746-2169 (Phone), (212) 746-8451 (Fax)
520 E 70Th St SUITE 341, New York 10021
(212) 746-2927 (Phone), (212) 746-8869 (Fax)
Cornell Medical Group
1300 York Ave SUITE 528, New York 10065
(212) 746-2988 (Phone)
New York Office
520 E 70Th St SUITE 341, New York 10021
(646) 962-2065 (Phone), (646) 962-1603 (Fax)
Cornell Medical Group
525 E 68Th St, New York 10065
(646) 962-2988 (Phone)
NATIONAL CORD BLOOD PROGRAM
310 E 67Th St, New York 10065
(212) 570-3229 (Phone), (212) 570-3393 (Fax)
310 E 67Th St SUITE 2-14, New York 10065
Certifications:
Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
NEW YORK HOSP CORNELL MED CTR
525 E 68Th St, New York 10065
310 E 67Th St SUITE 2-14, New York 10065
520 E 70Th St SUITE 341, New York 10021
NATIONAL CORD BLOOD PROGRAM
310 E 67Th St, New York 10065
Cornell Medical Group
1300 York Ave SUITE 528, New York 10065
New York Office
520 E 70Th St SUITE 341, New York 10021
Cornell Medical Group
525 E 68Th St, New York 10065
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1976
Ny Hosp


Jeffrey Laurence Photo 5
Human T Cell Hybridomas Which Produce Immunosuppressive Factors

Human T Cell Hybridomas Which Produce Immunosuppressive Factors

US Patent:
4665032, May 12, 1987
Filed:
Jun 28, 1984
Appl. No.:
6/625431
Inventors:
Jeffrey C. Laurence - New York NY
Assignee:
Cornell Research Foundation, Inc. - Ithaca NY
International Classification:
C12N 500, C12N 1500, C12R 191
US Classification:
435240
Abstract:
A human T cell hybridoma comprising the product of: (A) fusion of: (i) a T cell from a patient with ARC or AIDS, wherein said T cell secretes an SSF capable of specifically inhibiting T cell-dependent responses while leaving other immune functions intact, and (ii) a human T cell line, followed by (B) selection from the product of (A) of a human T cell hybridoma which secretes an SSF capable of specifically inhibiting T cell-dependent responses while leaving other immune functions intact.